Logo image of IMMR

IMMERSION CORPORATION (IMMR) Stock Fundamental Analysis

NASDAQ:IMMR - Nasdaq - US4525211078 - Common Stock - Currency: USD

7.05  +0.17 (+2.47%)

After market: 7.05 0 (0%)

Fundamental Rating

5

Taking everything into account, IMMR scores 5 out of 10 in our fundamental rating. IMMR was compared to 32 industry peers in the Technology Hardware, Storage & Peripherals industry. While IMMR is still in line with the averages on profitability rating, there are concerns on its financial health. IMMR scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

IMMR had positive earnings in the past year.
IMMR had positive earnings in 4 of the past 5 years.
IMMR had a positive operating cash flow in 4 of the past 5 years.
IMMR Yearly Net Income VS EBIT VS OCF VS FCFIMMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M

1.2 Ratios

IMMR has a Return On Assets of 2.86%. This is in the better half of the industry: IMMR outperforms 65.63% of its industry peers.
IMMR has a Return On Equity of 14.75%. This is amongst the best in the industry. IMMR outperforms 84.38% of its industry peers.
The Return On Invested Capital of IMMR (1.89%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for IMMR is significantly below the industry average of 16.47%.
The 3 year average ROIC (9.10%) for IMMR is well above the current ROIC(1.89%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.86%
ROE 14.75%
ROIC 1.89%
ROA(3y)13%
ROA(5y)5.72%
ROE(3y)15.61%
ROE(5y)6.28%
ROIC(3y)9.1%
ROIC(5y)N/A
IMMR Yearly ROA, ROE, ROICIMMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

1.3 Margins

With an excellent Profit Margin value of 100.17%, IMMR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
IMMR's Profit Margin has improved in the last couple of years.
The Operating Margin of IMMR (52.85%) is better than 100.00% of its industry peers.
In the last couple of years the Operating Margin of IMMR has grown nicely.
Industry RankSector Rank
OM 52.85%
PM (TTM) 100.17%
GM N/A
OM growth 3Y94.23%
OM growth 5Y2.01%
PM growth 3Y78.19%
PM growth 5Y15.41%
GM growth 3YN/A
GM growth 5YN/A
IMMR Yearly Profit, Operating, Gross MarginsIMMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 -100

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IMMR is creating some value.
Compared to 1 year ago, IMMR has less shares outstanding
IMMR has more shares outstanding than it did 5 years ago.
IMMR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IMMR Yearly Shares OutstandingIMMR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
IMMR Yearly Total Debt VS Total AssetsIMMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

IMMR has an Altman-Z score of 0.48. This is a bad value and indicates that IMMR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of IMMR (0.48) is worse than 68.75% of its industry peers.
A Debt/Equity ratio of 0.81 indicates that IMMR is somewhat dependend on debt financing.
IMMR has a Debt to Equity ratio of 0.81. This is comparable to the rest of the industry: IMMR outperforms 43.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Altman-Z 0.48
ROIC/WACC0.21
WACC8.91%
IMMR Yearly LT Debt VS Equity VS FCFIMMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.55 indicates that IMMR should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.55, IMMR is in line with its industry, outperforming 50.00% of the companies in the same industry.
A Quick Ratio of 0.72 indicates that IMMR may have some problems paying its short term obligations.
The Quick ratio of IMMR (0.72) is worse than 68.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 0.72
IMMR Yearly Current Assets VS Current LiabilitesIMMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.12% over the past year.
The Earnings Per Share has been decreasing by -9.60% on average over the past years.
IMMR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.81%.
The Revenue for IMMR have been decreasing by -21.11% on average. This is quite bad
EPS 1Y (TTM)14.12%
EPS 3Y47.44%
EPS 5Y-9.6%
EPS Q2Q%N/A
Revenue 1Y (TTM)-11.81%
Revenue growth 3Y3.61%
Revenue growth 5Y-21.11%
Sales Q2Q%-22.96%

3.2 Future

IMMR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.87% yearly.
The Revenue is expected to grow by 189.84% on average over the next years. This is a very strong growth
EPS Next Y75.07%
EPS Next 2Y62.1%
EPS Next 3Y10.87%
EPS Next 5YN/A
Revenue Next Year1039.86%
Revenue Next 2Y388.92%
Revenue Next 3Y189.84%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IMMR Yearly Revenue VS EstimatesIMMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
IMMR Yearly EPS VS EstimatesIMMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2 3

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.64, the valuation of IMMR can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of IMMR indicates a rather cheap valuation: IMMR is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.48, IMMR is valued rather cheaply.
IMMR is valuated cheaply with a Price/Forward Earnings ratio of 2.15.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IMMR indicates a rather cheap valuation: IMMR is cheaper than 93.75% of the companies listed in the same industry.
IMMR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.04.
Industry RankSector Rank
PE 5.64
Fwd PE 2.15
IMMR Price Earnings VS Forward Price EarningsIMMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IMMR is valued a bit cheaper than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.92
IMMR Per share dataIMMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

IMMR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IMMR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y62.1%
EPS Next 3Y10.87%

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.62%, IMMR has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.98, IMMR pays a better dividend. On top of this IMMR pays more dividend than 96.88% of the companies listed in the same industry.
IMMR's Dividend Yield is comparable with the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 2.62%

5.2 History

IMMR has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
IMMR Yearly Dividends per shareIMMR Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

DPN/A
EPS Next 2Y62.1%
EPS Next 3Y10.87%
IMMR Yearly Income VS Free CF VS DividendIMMR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M

More info and screens

IMMERSION CORPORATION

NASDAQ:IMMR (8/8/2025, 8:00:02 PM)

After market: 7.05 0 (0%)

7.05

+0.17 (+2.47%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)03-12 2025-03-12/bmo
Earnings (Next)08-18 2025-08-18
Inst Owners58.76%
Inst Owner Change0.88%
Ins Owners5.06%
Ins Owner Change-3.09%
Market Cap228.42M
Analysts82.5
Price Target12.5 (77.3%)
Short Float %6.82%
Short Ratio4.61
Dividend
Industry RankSector Rank
Dividend Yield 2.62%
Yearly Dividend0.23
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date07-23 2025-07-23 (0.045)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 5.64
Fwd PE 2.15
P/S 6.73
P/FCF N/A
P/OCF N/A
P/B 0.99
P/tB 1.88
EV/EBITDA 9.92
EPS(TTM)1.25
EY17.73%
EPS(NY)3.28
Fwd EY46.59%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.05
BVpS7.11
TBVpS3.74
PEG (NY)0.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.86%
ROE 14.75%
ROCE 2.39%
ROIC 1.89%
ROICexc 2.3%
ROICexgc 2.8%
OM 52.85%
PM (TTM) 100.17%
GM N/A
FCFM N/A
ROA(3y)13%
ROA(5y)5.72%
ROE(3y)15.61%
ROE(5y)6.28%
ROIC(3y)9.1%
ROIC(5y)N/A
ROICexc(3y)48.9%
ROICexc(5y)N/A
ROICexgc(3y)48.9%
ROICexgc(5y)N/A
ROCE(3y)11.5%
ROCE(5y)N/A
ROICexcg growth 3Y84.52%
ROICexcg growth 5YN/A
ROICexc growth 3Y84.52%
ROICexc growth 5Y-44.16%
OM growth 3Y94.23%
OM growth 5Y2.01%
PM growth 3Y78.19%
PM growth 5Y15.41%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Debt/EBITDA 10.37
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 0.72
Altman-Z 0.48
F-ScoreN/A
WACC8.91%
ROIC/WACC0.21
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)109.51%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.12%
EPS 3Y47.44%
EPS 5Y-9.6%
EPS Q2Q%N/A
EPS Next Y75.07%
EPS Next 2Y62.1%
EPS Next 3Y10.87%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.81%
Revenue growth 3Y3.61%
Revenue growth 5Y-21.11%
Sales Q2Q%-22.96%
Revenue Next Year1039.86%
Revenue Next 2Y388.92%
Revenue Next 3Y189.84%
Revenue Next 5YN/A
EBIT growth 1Y-26.59%
EBIT growth 3Y101.23%
EBIT growth 5Y-19.52%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-48.65%
FCF growth 3YN/A
FCF growth 5Y-21.67%
OCF growth 1Y-48.69%
OCF growth 3Y909.9%
OCF growth 5Y-21.68%